The State of AI Regulation in Healthcare: Still Complicated
A health law commentary details how the FDA continues to prioritize premarket review for higher-risk **clinical AI systems**, such as diagnostic imaging and pathology tools, while allowing more flexibility for low-risk workflow applications. It summarizes January 2026 guidance on clinical decision support software, clarifying that AI products directly influencing clinical judgment or treatment decisions will generally require FDA clearance or approval.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.